SCHEMBL9816209

SCHEMBL9816209

CCC(O)(c1ccccc1)N1CCNCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 3/20 0.48
CHRM4 P08173 3/20 0.48
CHRM5 P08912 3/20 0.48
CHRM1 P11229 3/20 0.48
CHRM3 P20309 3/20 0.48
OPRD1 P41143 1/20 0.42
KMT2A Q03164 3/20 0.41
LMNA P02545 2/20 0.41
CYP2D6 P10635 2/20 0.41
MEN1 O00255 2/20 0.41
HRH1 P35367 1/20 0.41
SCN1A P35498 1/20 0.41
SCN2A Q99250 1/20 0.41
SCN3A Q9NY46 1/20 0.41
SIGMAR1 Q99720 3/20 0.40
ADRB1 P08588 2/20 0.39
HTR3E A5X5Y0 1/20 0.39
HTR3B O95264 1/20 0.39
HTR3A P46098 1/20 0.39
HTR3D Q70Z44 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12806774 0.89 CHRM2 (0.47) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL12806749 0.86 CHRM3 (0.48) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL8013935 0.84 CYP2B6 (0.52) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL597167 0.84 CYP2B6 (0.52) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL18284710 0.83 ADRB1 (0.45) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL7547849 0.83 CYP2B6 (0.55) CHRM2CHRM4CHRM5CHRM1CHRM3
Hydrochloric Acid SCHEMBL8017738 0.83 CYP2B6 (0.50) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL1208824 0.82 CHRM2 (0.47) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL4541997 0.80 KCNA5 (0.48) OPRD1KMT2ALMNAMEN1KCNA5
SCHEMBL8818968 0.79 CHRM2 (0.43) CHRM2CHRM4CHRM5CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101512336-A Stimulation of pancreatic beta cell proliferation UNIV ROCKEFELLER (US) 2009-08-19 CN claimed
EP-0167121-B1 SUBSTITUTED PHENYLPIPERAZINYL PROPANOLS, PROCESS FOR THEIR PREPARATION, THEIR USE, AND COMPOSITIONS CONTAINING THESE COMPOUNDS Beiersdorf Aktiengesellschaft (DE) 1991-10-23 EP claimed
US-4631281-A ANTICOAGULANTS, ASTHMA, HYPOTENSIVE AGENTS, BRONCHOPILATORS, INOTROPIC AGENTS BEIERSDORF AKTIENGESELLSCHAFT (DE) 1986-12-23 US claimed
EP-0167121-A2 Substituted phenylpiperazinyl propanols, process for their preparation, their use, and compositions containing these compounds Beiersdorf Aktiengesellschaft (DE) 1986-01-08 EP claimed
CN-101512336-A Stimulation of pancreatic beta cell proliferation UNIV ROCKEFELLER (US) 2009-08-19 CN disclosed
EP-0167121-B1 SUBSTITUTED PHENYLPIPERAZINYL PROPANOLS, PROCESS FOR THEIR PREPARATION, THEIR USE, AND COMPOSITIONS CONTAINING THESE COMPOUNDS Beiersdorf Aktiengesellschaft (DE) 1991-10-23 EP disclosed
EP-0167121-B1 SUBSTITUTED PHENYLPIPERAZINYL PROPANOLS, PROCESS FOR THEIR PREPARATION, THEIR USE, AND COMPOSITIONS CONTAINING THESE COMPOUNDS Beiersdorf Aktiengesellschaft (DE) 1991-10-23 EP disclosed
US-4994459-A Aryloxypropane substituted piperazine derivatives with antiarrhythmic and antifibrillatory activity AMERICAN HOME PRODUCTS CORPORATION (US) 1991-02-19 US disclosed
US-4631281-A ANTICOAGULANTS, ASTHMA, HYPOTENSIVE AGENTS, BRONCHOPILATORS, INOTROPIC AGENTS BEIERSDORF AKTIENGESELLSCHAFT (DE) 1986-12-23 US disclosed
US-4631281-A ANTICOAGULANTS, ASTHMA, HYPOTENSIVE AGENTS, BRONCHOPILATORS, INOTROPIC AGENTS BEIERSDORF AKTIENGESELLSCHAFT (DE) 1986-12-23 US disclosed
US-4631281-A ANTICOAGULANTS, ASTHMA, HYPOTENSIVE AGENTS, BRONCHOPILATORS, INOTROPIC AGENTS BEIERSDORF AKTIENGESELLSCHAFT (DE) 1986-12-23 US disclosed
EP-0167121-A2 Substituted phenylpiperazinyl propanols, process for their preparation, their use, and compositions containing these compounds Beiersdorf Aktiengesellschaft (DE) 1986-01-08 EP disclosed
EP-0034276-B1 PHENYLPIPERAZINE DERIVATIVES OF 1,3,4-OXADIAZOLYL PHENOLS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM BASF Aktiengesellschaft (DE) 1983-11-09 EP disclosed
US-4353904-A TREATMENT OF HYPERTONIA BASF AKTIENGESELLSCHAFT (DE) 1982-10-12 US disclosed
US-4353904-A TREATMENT OF HYPERTONIA BASF AKTIENGESELLSCHAFT (DE) 1982-10-12 US disclosed
EP-0056866-A2 Phenylpiperazine derivatives of heterylphenols and hetarylanilines, their preparation and their pharmaceutical compositions BASF Aktiengesellschaft (DE) 1982-08-04 EP disclosed
EP-0056486-A2 Phenylpiperazinyl-propanoles of hetarylphenols, their preparation and their pharmaceutical compositions BASF Aktiengesellschaft (DE) 1982-07-28 EP disclosed
EP-0056486-A2 Phenylpiperazinyl-propanoles of hetarylphenols, their preparation and their pharmaceutical compositions BASF Aktiengesellschaft (DE) 1982-07-28 EP disclosed
EP-0056486-A2 Phenylpiperazinyl-propanoles of hetarylphenols, their preparation and their pharmaceutical compositions BASF Aktiengesellschaft (DE) 1982-07-28 EP disclosed
EP-0034276-A2 Phenylpiperazine derivatives of 1,3,4-oxadiazolyl phenols, their preparation and pharmaceutical compositions containing them BASF Aktiengesellschaft (DE) 1981-08-26 EP disclosed